-
NMTRC14: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
If you or your child have been diagnosed with neuroblastoma that is now in remission, you or your child may be qualified to participate in ... -
Paroxysmal nocturnal hemoglobinuria (PNH) Registry
This is a non interventional registry to gather information on the clinical presentation and outcomes of patients with PNH. The PHN Registry will capture post-marketing ... -
Controlling Behcet's Uveitis Through Transfer of Ex-Vivo Expanded Regulatory T Cells
The purpose of the study is to examine blood samples from patients with Behcet’s Syndrome (a disease, which causes inflammation of the blood vessels ... -
RELAXaHEAD for Headache Patients
The purpose of this study is to examine ways to decrease the disability associated with migraine attacks. We are looking to enroll patients with smartphones ... -
Effects of Elevated Intraocular Pressure on Lamina Cribrosa
The purpose of this research study is to examine how the lamina cribrosa, a layer of tissue in the back of the eye, responds to ... -
NYU Diabetes Biobank and Database
We are looking for participants with a diagnosis of diabetes or with a brother or sister with diabetes. The purpose of this study is to ... -
NYU Validation of a Food Frequency Questionnaire in Children and Adolescents with Diabetes
The purpose of this study is to create and “validate” an improved questionnaire about food intake in children with diabetes that also looks at exposure ... -
NYU Pediatric Diabetes Database and Biobank
We are looking for participants with a diagnosis of diabetes or with a brother or sister with diabetes. The purpose of this study is to ... -
Colorectal Cancer Metastatic MSI-High Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Micros
If you have been diagnosed with Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer, you may qualify for this Phase 3 study. The main goal of this ... -
DART: DUAL ANTI-CTLA-4 AND ANTI-PD-1 BLOCKADE IN RARE TUMORS
If you have been diagnosed with a rare cancer or a rare cancer of unknown primary origin, you may qualify for this study. The main ...